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After 11 mm for completion of the antigen-antibody and enzyme donor-enzyme acceptor reactions, the digoxin concentration in the sample is calculated from the galactosidase activity.
We used this assay in the Cobas-Bio centrifugal analyzer (Roche Diagnostics, Inc., Nutley, NJ), with which we could study 28 reactions concurrently during their entire course. After re-determining the optimal reaction timing, we measured the precision of the assay and compared results with those obtained by radioinimunoassay.
MaterIals and Methods

Materials:
Aliquots of patients' samples sent to the clinical laboratory for digoxin assay were studied. CEDIA and RIA reagents were both reconstituted according to the suppliers' instructions. This permitted the simultaneous reactions of ED with antibody, combination of the remaining ED with EA, and interaction of the substrate with the enzyme. The enzyme activity was then estimated from the rate of change of absorbance at 420 nm, calculated from readings at 10-s intervals for the next 3.5 mm. The concentrations of digoxin in patients' samples were computed from the standard curve established during the run.
Each assay was done in duplicate. Initially, samples were assayed by RIA and CEDIA on the same day. After study indicated that the CEDIA assay result was unchanged when samples were stored at 5 #{176}C, samples from specimens were assayed by RIA and another aliquot was refrigerated and assayed by CEDIA the following morning.
Reagent stability: In a typical CEDIA assay, three calibrators containing 0, 2, and 4 ng/mL; two immunoassay controls; and as many as 20 serum samples were analyzed concurrently. In some experiments, parallel assays were carried out with freshly reconstituted reagents and with reagents already reconstituted but stored for various periods, so we could assess the effect of such storage on assay performance.
Reaction kinetics:
In an attempt to re-determine the optimum measurement time, we measured the enzyme activity of several reaction mixtures at 1, 5, and 10 min after mixing had been initiated.
Results
Precision: Within-run coefficients of variation (CVs) for assays of the three control samples ranged from 1% to 3%; day-to-day CVs over a 20-day interval ranged from 3.5% to 11.2% (Table 1) .
Accuracy:
Results of assays of 90 patients' sera by the two methods correlated well (Figure 1 ): CEDIA, ng/mL 1.00 x RIA -0.06 ng/mL (r = 0.95, S = 0.05).
Interferences: Hemolysis did not interfere in the CEDIA assay. One severely lipemic sample gave a result 30% lower than that obtained with the RIA method.
Stability of reagents: Assays of three control solutions with either freshly reconstituted reagents or reagents stored at 5#{176}C for different intervals before assay gave indistinguishable results. The precision of assays repeated on five successive days was the same for patients' samples, serum pools, and control solutions ( Table 2) . Assays of the CEDIA calibrator solutions as samples along with control solutions agreed with the set-in values ( Table 3) .
Effect of sample dilution: Two samples containing high concentrations of thgoxin were assayed after diluting one sample with isotonic saline and the other with the "zero diluent" supplied with the CEDIA kit. Sera diluted as much as twofold with isotonic saline or up to threefold with zero diluent gave results proportional to the digoxin concentration. Samples diluted more than threefold gave disproportionately higher results, ranging from 12.5% to 25% more than expected (Table 4) . Also, fourfold or greater dilution of a digoxin solution (4.63 ng/mL) with pooled serum yielded disproportionately higher results ( Table 5) . Similar failure of proportionality has been noted in other immunoassays (4) (5) (6) and is sometimes attributed to changes in the protein and lipid content Kinetics of the reaction: Pre-incubation of serum containing digoxin with the antibody for intervals ranging from 30 s to 10 mm had little effect on the final enzyme activity. From this we conclude that combination of the digoxin conjugatewith the antibody proceeds appreciablyfaster than combinationofthe conjugatewith the ED. duced the only apparentoutlier in the comparison with the was diluted with isotonic saline; serum2, withzero diluent.
RIA method, but thatconstituted a difference ofonly 1.2to 1.6 ng/mL. The initial high absorbance of the sample _____________________________________________ rendered difficult the discrimination of small absorbance Table 5 . Effect of Serial Dilutions on RIA and CEDIA changes.
Assay Results
The reagents were stable to storage at 5 #{176}C for at least a week without noticeable deterioration. Measured dlgoxln concn, ng/mL
